Skip to the page

Data / Form D filings / Opus Genetics Inc.

Opus Genetics Inc.: Form D filings

Opus Genetics Inc., a biotechnology company in Durham, NC, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on June 27, 2023, reports $4.5 million sold of a $20 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8 DAVIS DRIVE, SUITE 220, Durham, NC, 27709
Phone
(919) 525-9820
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1877769

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 27, 2023New notice$20,000,000$4,501,972$15,498,0285Jun 5, 2023sec.gov
Aug 20, 2021New notice$19,000,001$9,500,001$9,500,0005Aug 5, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
JEAN R. BENNETTDirector
RUSSELL R. KELLEYDirector
BENJAMIN R. YERXAExecutive Officer, Director
ADRIENNE R. GRAVESDirector

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Jun 26, 2023 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Opus Genetics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.